News

Filter

Current filters:

RocheCardio-vascular

1 to 9 of 16 results

Janssen and HemoShear identify vascular health benefits of RA drugs

Janssen and HemoShear identify vascular health benefits of RA drugs

11-11-2014

US biotech firm HemoShear and Janssen Research and Development plan to report data showing that a subset…

ActemraAnti-Arthritics/RheumaticsBiotechnologyCardio-vascularHemoShearJanssen Research and DevelopmentJohnson & JohnsonResearchRochesirukumabUSA

Added indications recommended by EMA/CHMP

Added indications recommended by EMA/CHMP

27-06-2014

Along with backing for approval for six news drugs issued at the late June meeting of the European Medicines…

AvastinBayerBristol-Myers SquibbCardio-vascularEliquisEuropeEyleaKalydecoOncologyOphthalmicsPfizerPharmaceuticalRare diseasesRegulationRocheVertex Pharmaceuticals

EMA turns positive on orlistat and aprotinin; CHMP backs Pixuvri

20-02-2012

Finalizing its review on orlistat-containing medicines and the possible risk of severe liver injuries,…

AlliBayerBiotechnologyCardio-vascularCell TherapeuticsEuropeGlaxoSmithKlineMetabolicsOncologyorlistatPharmaceuticalPixuvriRegulationRocheTrasylolXenical

UK NICE nixes three colorectal cancer drugs; gives nod to blood thinner Eliquis

25-11-2011

In a batch of mixed news coming from the UK’s National Institute for Health and Clinical Excellence…

AmgenAvastinBristol-Myers SquibbCardio-vascularEliquisErbituxMerck & CoMerck SeronoOphthalmicsPfizerPharmaceuticalPricingRegulationRocheVectibix

Spotlight on Roche dalcetrapib data to be presented at ESC

22-08-2011

An abstract summarizing partial results from the Phase II dal-PLAQUE trial with Swiss drug major Roche’s…

Cardio-vasculardalcetrapibPharmaceuticalResearchRoche

Roche joins forces with ChemRar on developing new antithrombotic drug for Russia

30-05-2011

Swiss pharmaceutical major Roche (ROG: SIX) and Russian TeaReks company, a subsidiary of ChemRar, Roche's…

Cardio-vascularChemRar Hi-TechEuropeLicensingPharmaceuticalRocheTeaReks

Serodus buys rights to Roche drug for potential treatment of heart failure

14-12-2010

Norway’s Serodus has entered into a license agreement with Swiss drug major Roche (ROG: VX) for…

Cardio-vascularLicensingPharmaceuticalRocheSerodus

1 to 9 of 16 results

Back to top